Neurology News

The FDA has approved Medtronic’s Asleep Deep Brain Stimulation surgery for individuals diagnosed with Parkinson’s disease as well as those with essential tremor, according to the manufacturer.

Apixaban and aspirin offered similar protection against major ischemic and hemorrhagic events among people with cancer history and cryptogenic stroke.

An investigational, fully human monoclonal antibody developed as a muscle-targeted therapy for spinal muscular atrophy showed sustained motor function improvements at 48 months, according to the manufacturer.

As your paycheck grows, so does your discretionary spending and saving. While it is easy to spend, it is not always clear where to invest your next dollar intended for future spending.

Bypassing the blood-brain barrier remains an obstacle for novel therapeutics. Healio spoke to Thomas Chen, MD, PhD, founder and CEO of NeOnc, to find out how a novel nasal spray formulation to treat brain cancer overcomes these challenges.

Neurotechnology company Synchron announced the first use of Apple Vision Pro with a patient implanted with its brain-computer interface, which allows users to make commands without using their hands or voice.

The FDA has approved Crexont extended-release capsules for the treatment of Parkinson’s disease, according to the manufacturer.

PHILADELPHIA — A computerized cognitive battery was effective in detecting cognitive impairment and amyloid presence in preclinical Alzheimer’s disease, James E. Galvin, MD, MPH, said in this Healio Video Perspective.

Short-interval high-intensity exercise after stroke improved oxygen consumption and may reduce risk for future strokes and hospitalizations, according to a study published in Stroke.

Adults who received the recombinant zoster vaccine had a significantly lower risk for dementia over the next 6 years compared with live vaccine recipients, study results published in Nature Medicine revealed.